HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2

Erstveröffentlichung

2017

Authors

Hanker, Ariella B.

Garrett, Joan T.

Estrada, Monica Valeria

Moore, Preston D.

Ericsson, Paula Gonzalez

et al.

Wissenschaftlicher Artikel

Published in

Clinical Cancer Research ; 23 (2017), 15. - S. 4323-4334. - ISSN 1078-0432. - eISSN 1557-3265

Link to publication

https://dx.doi.org/10.1158/1078-0432.CCR-16-2287

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Subject headings

[Free subject headings]: kinase inhibitor lapatinib | ccnd1 amplification | acquired-resistance | erbb receptors | solid tumors | open-label | growth | trastuzumab | oncogene | cells
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record